Y. PAUL GOLDBERG Insider Trading
Get free email notifications about insider trading for Y. PAUL GOLDBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Y. PAUL GOLDBERG. Y. PAUL GOLDBERG is a SVP, Clinical Development in Xenon Pharmaceuticals Inc. ($XENE) and a VP of Clinical Development in Xenon Pharmaceuticals Inc. ($XENE) and a VP, Clinical Development in Xenon Pharmaceuticals Inc. ($XENE).
Address: C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY BURNABY V5G 4W8 A1
Companies in which Y. PAUL GOLDBERG is an Insider
Xenon Pharmaceuticals Inc.
Trading Symbol: XENEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Y. PAUL GOLDBERG: SVP, Clinical Development, VP of Clinical Development, VP, Clinical Development
Holdings: 6,000 shares
Current Value: $49,200
Latest Transaction: Oct 24 2017
$XENE Market Capitalization: $145.83M
$XENE Previous Close: $8.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Y. PAUL GOLDBERG
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 24 2017 | XENE | Xenon Pharmaceutic ... | GOLDBERG Y. PAUL | SVP, Clinical Devel ... | Option Exercise | A | 3.10 | 11,000 | 34,100 | 11,000 | |
Mar 14 2017 | XENE | Xenon Pharmaceutic ... | GOLDBERG Y. PAUL | SVP, Clinical Devel ... | Option Exercise | A | 8.40 | 27,500 | 231,000 | 27,500 | |
Mar 11 2016 | XENE | Xenon Pharmaceutic ... | GOLDBERG Y. PAUL | VP, Clinical Develo ... | Option Exercise | A | 7.49 | 20,000 | 149,800 | 20,000 | |
Dec 21 2015 | XENE | Xenon Pharmaceutic ... | GOLDBERG Y. PAUL | VP of Clinical Deve ... | Option Exercise | A | 7.69 | 15,000 | 115,350 | 15,000 | |
Sep 24 2015 | XENE | Xenon Pharmaceutic ... | GOLDBERG Y. PAUL | VP of Clinical Deve ... | Option Exercise | M | 2.68 | 785 | 2,104 | 243 | |
Sep 24 2015 | XENE | Xenon Pharmaceutic ... | GOLDBERG Y. PAUL | VP of Clinical Deve ... | Option Exercise | M | 2.68 | 7,973 | 21,368 | 4,372 | |
Sep 24 2015 | XENE | Xenon Pharmaceutic ... | GOLDBERG Y. PAUL | VP of Clinical Deve ... | Option Exercise | M | 3.73 | 3,115 | 11,619 | 1,000 |